Get informed when a big investor buys or sells
+ FollowOvervalued by 130.8% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $2.51 Million |
|---|---|
| Enterprise Value | $3.62 Million |
| Earnings per Share | $-0.02 |
| Beta | 0.24 |
| Outstanding Shares | 100,430,472 |
| P/E Ratio | -1.96 |
|---|---|
| PEG | 29.77 |
| Price to Sales | - |
| Price to Book Ratio | -0.03 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.67 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.4 |
| Debt to Equity | -0.91 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Telo Genomics Corp. is a biotechnology enterprise focused on developing and commercializing sophisticated predictive technologies. Their mission is to enable personalized treatment approaches for patients facing specific health challenge...